Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-10-20

Clinical Trial Update: 1% Metformin Gel in the Treatment of Class II Furcation Defects [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluated 1% metformin gel for class II furcation defects in chronic periodontitis. The study has completed its Phase 2 and Phase 3 c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Metformin Gel (1%) (metformin)

Snippet

Sponsor: Government Dental College and Research Institute, Bangalore | Conditions: Chronic Periodontitis | Phase 2, Phase 3 | Status: COMPLETED